Synergy Rx vs Zealthy

Cons

• ✗Runs on the same Lion MD clinician network and the same 4 compounding pharmacies as Breeze Meds and Care Bare Rx — the three brands are white-labeled storefronts on top of one underlying operation
• ✗Mandatory individual arbitration + class action waiver in ToS (30-day opt-out window from signup)
• ✗Consultation fees are non-refundable and all prescription sales are final per ToS
• ✗Platform explicitly disclaims liability for third-party pharmacy medication quality: 'SynergyRx makes no representations or warranties regarding the efficacy, safety, or outcomes of any medication provided through these third parties'
• ✗State availability is 'subject to each state's telehealth and prescribing regulations' — the full list of active states requires contacting customer service rather than being published
• ✗Do NOT confuse with the unrelated 'Synergy Rx Pharmacy' (San Diego, CA) that issued a voluntary nationwide recall in February 2017 for non-sterile compounded products — that is a different entity in a different state
• ✗Do not visit synergyrx.com — it is a parked domain on Sedo and unrelated to the telehealth brand. The correct domain is synergyrx.co

Cons

• ✗TWO FDA warning letters for false/misleading marketing of compounded GLP-1s (Feb 2026 letter 717987 verified at fda.gov; September 2025 letter from secondary sources)
• ✗Active Novo Nordisk false-advertising lawsuit: Novo Nordisk A/S et al v. Zealthy Inc., case 1:25-cv-06391 (S.D.N.Y., filed 2025-08-04), alleging trademark infringement and marketing of compounded products as 'FDA-approved alternatives'
• ✗Active DOJ/FTC enforcement: United States v. Cerebral, Inc. et al, case 1:24-cv-21376 (S.D. Fla., amended complaint adding Zealthy Inc., Gronk Inc., founder Kyle Robertson, and others), alleging ROSCA violations (failure to disclose subscription terms, no informed consent for billing, locked cancellation), and unauthorized health-data sharing for targeted advertising
• ✗Founder pattern of conduct: Kyle Robertson previously founded Cerebral, which settled with the FTC in June 2024 ($5M consumer redress + $10M civil penalty suspended to $2M) for similar deceptive practices. Robertson then founded Zealthy and is alleged to have continued the same conduct
• ✗Company recently renamed FitRX/Zealthy to Gronk Inc. — rebrand pattern is itself a concerning signal in the context of active enforcement
• ✗Continued marketing of compounded semaglutide after FDA removed it from the shortage list on 2025-02-21 (post-shortage compounding without legal authorization)
• ✗Adds a $135/month membership fee on top of medication cost — total cash price is $286-$351/month
• ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro option